The EMPERIAL (Effect of EMPagliflozin on ExeRcise ability and HF symptoms in patients with chronic heArt faiLure) trials evaluated the effect of 10 mg empagliflozin versus placebo on exercise ability in patients with heart failure. EMPERIAL-Reduced (NCT03448419) randomized 312 patients with heart failure with reduced ejection fraction (LVEF ≤ 40%) to receive either … [Read more...] about Effect of Empagliflozin on exercise ability and symptoms in heart failure patients
Cardiac surgery
Top Cardiology Conferences 2021
With the COVID-19 worldwide pandemic, conferences and congresses planned for 2020 converted to either a digital format or were cancelled. Looking ahead to 2021, conferences planned for the first quarter will still proceed virtually. Many of the most popular and well attended conferences occurring later in the year hope to proceed once again in-person. However, they are keeping … [Read more...] about Top Cardiology Conferences 2021
SAMSON Trial: Role of nocebo effect in statin-associated muscle symptoms
The phenomenon of non-adherence to statin therapy is well known. Reasons for discontinuation include elevated hepatic or muscular enzymes, neurological symptoms, and muscular symptoms collectively referred to as statin-associated muscle symptoms (SAMS).1 SAMS seems to occur less frequently in randomized control trials than in observational studies. These results suggest that … [Read more...] about SAMSON Trial: Role of nocebo effect in statin-associated muscle symptoms
Top 10 Highlights of AHA 2020 Congress
The American Heart Association (AHA) 2020 congress took place virtually this year, from November 13 to 17, 2020. Here is our curated list of the top scientific sessions from AHA 2020. SOLOIST-WHF trial1: Sotagliflozin superior to placebo in preventing deaths and hospitalizations in patients with type 2 diabetes and worsening heart failure. This multicenter, double-blind … [Read more...] about Top 10 Highlights of AHA 2020 Congress
Top 10 highlights of ESC Congress 2020
This year’s European Society of Cardiology (ESC) congress was the first ever to be held entirely digitally, due to the COVID-19 pandemic. Approximately 116,000 healthcare providers from 211 countries participated, and there were many illuminating presentations shared to help guide the management of cardiovascular disease. Here are our top 10 highlights listed by … [Read more...] about Top 10 highlights of ESC Congress 2020